Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

SLC22A2 inhibitor

DRUG CLASS:

SLC22A2 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

MET exon 14 mutation

Non Small Cell Lung Cancer

Sensitive: C3 – Early Trials

Sensitive: C3 – Early Trials